We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCS
11926
PUT
DELISTED
Steelcase
SCS
$39.1K ﹤0.01%
3,500
-7,000
-67% -$61.3K
GPRK icon
11927
PUT
GeoPark
GPRK
$615M
$39.1K ﹤0.01%
3,800
+1,600
+73% +$15.6K
REVB icon
11928
Revelation Biosciences
REVB
$4.1M
$39K ﹤0.01%
+10
New +$44.1K
STHO icon
11929
PUT
Star Holdings Shares of Beneficial Interest
STHO
$118M
$39K ﹤0.01%
3,115
-1,105
-26% -$15.4K
HRT
11930
PUT
DELISTED
HireRight Holdings Corporation
HRT
$39K ﹤0.01%
4,100
-200
-5% -$2.06K
LE icon
11931
Lands' End
LE
$384M
$38.9K ﹤0.01%
5,214
-32,944
-86% -$280K
KC
11932
PUT
Kingsoft Cloud Holdings
KC
$3.51B
$38.9K ﹤0.01%
7,900
-5,800
-42% -$32.8K
SPAB icon
11933
CALL
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.93B
$38.9K ﹤0.01%
+1,600
New +$39.9K
XHR
11934
PUT
Xenia Hotels & Resorts
XHR
$1.77B
$38.9K ﹤0.01%
3,300
-600
-15% -$7.23K
LINC icon
11935
CALL
Lincoln Educational Services
LINC
$950M
$38.9K ﹤0.01%
+4,600
New +$36.3K
AVNT icon
11936
PUT
Avient
AVNT
$4.25B
$38.9K ﹤0.01%
1,100
+500
+83% +$19.4K
LSTA icon
11937
Lisata Therapeutics
LSTA
$9.82M
$38.8K ﹤0.01%
18,582
+1,404
+8% +$3.9K
DBO icon
11938
PUT
Invesco DB Oil Fund
DBO
$391M
$38.8K ﹤0.01%
2,200
-5,400
-71% -$87.8K
WLDN icon
11939
PUT
Willdan Group
WLDN
$1.32B
$38.8K ﹤0.01%
1,900
+1,700
+850% +$36K
AIA icon
11940
CALL
iShares Asia 50 ETF
AIA
$5.06B
$38.8K ﹤0.01%
+700
New +$41.2K
ORGO icon
11941
PUT
Organogenesis Holdings
ORGO
$230M
$38.8K ﹤0.01%
12,200
-900
-7% -$2.86K
ORGN
11942
CALL
DELISTED
Origin Materials
ORGN
$38.8K ﹤0.01%
1,010
-403
-29% -$31.6K
AHT
11943
CALL
Ashford Hospitality Trust
AHT
$20.8M
$38.7K ﹤0.01%
1,620
-580
-26% -$18.4K
AUVI
11944
DELISTED
Applied UV, Inc. Common Stock
AUVI
$38.7K ﹤0.01%
+4,804
New +$80.4K
SGMO
11945
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$38.7K ﹤0.01%
64,500
+7,300
+13% +$7.82K
SKE
11946
CALL
Skeena Resources
SKE
$4.15B
$38.6K ﹤0.01%
+8,400
New +$40.8K
CHCT
11947
CALL
Community Healthcare Trust
CHCT
$432M
$38.6K ﹤0.01%
1,300
-500
-28% -$16.8K
UDN icon
11948
PUT
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
$38.6K ﹤0.01%
2,100
+1,200
+133% +$22.6K
ZTEK
11949
Zentek
ZTEK
$77.3M
$38.4K ﹤0.01%
30,499
+3,358
+12% +$4.87K
AVNS
11950
CALL
DELISTED
Avanos Medical
AVNS
$38.4K ﹤0.01%
1,900
+600
+46% +$13.6K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.